PT - JOURNAL ARTICLE AU - Paranjpe, Ishan AU - Russak, Adam J AU - De Freitas, Jessica K AU - Lala, Anuradha AU - Miotto, Riccardo AU - Vaid, Akhil AU - Johnson, Kipp W. AU - Danieletto, Matteo AU - Golden, Eddye AU - Meyer, Dara AU - Singh, Manbir AU - Somani, Sulaiman AU - Manna, Sayan AU - Nangia, Udit AU - Kapoor, Arjun AU - O’Hagan, Ross AU - O’Reilly, Paul F AU - Huckins, Laura M AU - Glowe, Patricia AU - Kia, Arash AU - Timsina, Prem AU - Freeman, Robert M AU - Levin, Matthew A AU - Jhang, Jeffrey AU - Firpo, Adolfo AU - Kovatch, Patricia AU - Finkelstein, Joseph AU - Aberg, Judith A AU - Bagiella, Emilia AU - Horowitz, Carol R AU - Murphy, Barbara AU - Fayad, Zahi A AU - Narula, Jagat AU - Nestler, Eric J AU - Fuster, Valentin AU - Cordon-Cardo, Carlos AU - Charney, Dennis S AU - Reich, David L AU - Just, Allan C AU - Bottinger, Erwin P AU - Charney, Alexander W AU - Glicksberg, Benjamin S AU - Nadkarni, Girish N AU - on behalf of the Mount Sinai Covid Informatics Center (MSCIC) TI - Clinical Characteristics of Hospitalized Covid-19 Patients in New York City AID - 10.1101/2020.04.19.20062117 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.19.20062117 4099 - http://medrxiv.org/content/early/2020/04/26/2020.04.19.20062117.short 4100 - http://medrxiv.org/content/early/2020/04/26/2020.04.19.20062117.full AB - Background The coronavirus 2019 (Covid-19) pandemic is a global public health crisis, with over 1.6 million cases and 95,000 deaths worldwide. Data are needed regarding the clinical course of hospitalized patients, particularly in the United States.Methods Demographic, clinical, and outcomes data for patients admitted to five Mount Sinai Health System hospitals with confirmed Covid-19 between February 27 and April 2, 2020 were identified through institutional electronic health records. We conducted a descriptive study of patients who had in-hospital mortality or were discharged alive.Results A total of 2,199 patients with Covid-19 were hospitalized during the study period. As of April 2nd, 1,121 (51%) patients remained hospitalized, and 1,078 (49%) completed their hospital course. Of the latter, the overall mortality was 29%, and 36% required intensive care. The median age was 65 years overall and 75 years in those who died. Pre-existing conditions were present in 65% of those who died and 46% of those discharged. In those who died, the admission median lymphocyte percentage was 11.7%, D-dimer was 2.4 ug/ml, C-reactive protein was 162 mg/L, and procalcitonin was 0.44 ng/mL. In those discharged, the admission median lymphocyte percentage was 16.6%, D-dimer was 0.93 ug/ml, C-reactive protein was 79 mg/L, and procalcitonin was 0.09 ng/mL.Conclusions This is the largest and most diverse case series of hospitalized patients with Covid-19 in the United States to date. Requirement of intensive care and mortality were high. Patients who died typically had pre-existing conditions and severe perturbations in inflammatory markers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was Supported by U54 TR001433-05, National Center for Advancing Translational Sciences, National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA